Ren, Jie
Lu, Qiang
Fei, Xiang
Dong, Yi
D´Onofrio, Mirko
Sidhu, Paul S.
Dietrich, Christoph F. http://orcid.org/0000-0001-6015-6347
Article History
Received: 16 June 2023
Revised: 29 August 2023
Accepted: 31 August 2023
First Online: 22 November 2023
Declarations
:
: The scientific guarantor of this publication is Prof. Christoph F Dietrich.
: Paul S. Sidhu was Principal Investigator for Phase 3 clinical trials for SonoVue and Sonazoid.Paul S. Sidhu has received lecture fees from GE healthcare, Philips, Siemens, Bracco, Samsung.Paul S. Sidhu has received research support from GE and SamsungChristoph F Dietrich was Principal Investigator for Phase 3 clinical trials for SonoVue.Christoph F Dietrich has received lecture fees from Bracco, Siemens, Mindray, Hitachi, JAZZ, and Janssen.Christoph F Dietrich and Paul S. Sidhu has received research support from Mindray, GE Healthcare, Fresenius, Youkey, and Schallware.The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required for this study because it is a meta-analysis.
: Institutional Review Board approval was not required because it is a meta-analysis.
: No study subjects or cohorts have been previously reported.
: • Performed at one institution